Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2026-01-28 @ 12:44 PM
Study NCT ID:
NCT02629861
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2015-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-10
First Submit QC Date:
None
Study First Post Date:
2015-12-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-10
Results First Submit QC Date:
None
Results First Post Date:
2018-11-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-04-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-11-06
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL